Searchable abstracts of presentations at key conferences in endocrinology

ea0022p241 | Clinical case reports and clinical practice | ECE2010

Macroprolactinoma after chronic buserelin treatment in patient with prostate cancer

Laszlo Ferenc A , Gervain Mihaly , Voros Erika , Molnar Andor H , Laszlo Ferenc

Twelve years following hemicolectomy for colon adenocarcinoma, a 75-year-old patient with prostate cancer was treated for 4 weeks with the antiandrogen nilutamide and then with the long-acting GnRH agonist buserelin. The serum testosterone and prostate-specific antigen (PSA) levels had decreased dramatically after 3 months of treatment. After 2 years of buserelin administration, the hormonal state was examined. Serum estradiol, testosterone, DHEA, DHEAS, FSH and LH levels prov...

ea0022p168 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme-oxigenase synthase

Posa Aniko , Szablics Peter , Vari Beata , Szalai Zita , Kiss Gyongyi Karcsune , Varga Csaba , Laszlo Ferenc

In the reproductive age, it is well-known that males are more sensitive to cardiovascular ischemic disease than females. In our study, we investigated the role of heme-oxigenase synthase (HO), which produce endogenous vascular protective carbon monoxide, in the development of sexual dimorphism in rats. We found that HO synthase enzyme activity, and the expression its HO-1 and HO-2 isoenzyme were increased in female rat aorta and left heart ventricle compared to males. Moreover...